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Abstract: Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules
and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid
rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/,
alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an
exclusive energy source (i.e., as ‘food’, identified in the digestive system and body) in a hermetically isolated microdrop
environment, increasing their survival. As regards Aβ1–42, five other bdelloid rotifer species were also found to be able
to perform this phenomenon. Based on our experiments, the Aβ1–42-treated bdelloid rotifers demonstrate significantly
increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ±
2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal
species have so far been reported to have a similar capability. For all other microscopic species tested, including
monogonant rotifers and non-rotifers, the treatment with Aβ1–42 aggregates proved to be either toxic or simply
ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of
neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a
new preclinical perspective on therapeutic research in human neurodegenerative diseases.
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Introduction
Neurodegenerative disorders, such as Alzheimer’s
disease (AD), Parkinson’s disease (PD), and prion dis-
ease, could be regarded as phenotypes secondary to
the progressive functional impairment of proteomes.
[29, 52, 53]. The molecular basis of aging in the brain
may be described as an accelerated accumulation ac-
companied by a decreased clearance and degradation
of misfolded proteins [46]. There is a clear correlation
between protein aggregation and aged-related patholo-
gies. The intramolecular regions arranged in β-sheet
conformation are highly resistant to enzymatic deg-
radation. [32, 51] The various neurotoxic aggregates,
such as those composed of beta-amyloid (Aβ), alpha-
synuclein (α-Syn), and prion (normal cellular prion
protein /PrPC/ and pathogenic prion protein ‘scrapie’
/PrPSc/), share common features, with their accumu-
lation and aggregation facilitating neurodegeneration.
The peptide and protein aggregates in neurodegenera-
tive diseases have several characteristics in common;
however, their different molecular structures and
pathomechanism may lead to differences in their
toxicity [38]. Therefore, investigation of aggregate
degradation has emerged from a marginal area of
protein chemistry to become a highly relevant field in
neuropharmacological science [25]. Although the
pathological role of these aggregates has been well
established, at present, no universal and satisfactory
method exists for their in vivo degradation as a
potential therapeutic tool. Misfolded peptide and
protein aggregates can be partially digested by several
endogenous enzymes, such as insulin-degrading
enzyme (IDE) [23], neprilysin (NEP) [16], endothelin-
converting enzyme [12], angiotensin-converting en-
zyme [14], plasmin [47] and matrix metalloproteinases
[1]; however, their presence and function is apparently
insufficient in a scenario that leads to neurodegenera-
tive disorders.
Amyloids, such as Aβs, are key molecules in aging-
associated diseases, representing a starting point in the
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development of dementias. Therefore, their accumula-
tion is one of the most important toxic processes during
the course of cerebral Aβ-related pathologies, which is
potentiated by a reduced clearance and insufficient
degradation [30]. The understanding and modulation of
Aβ toxicity and its metabolism might provide novel
approaches in the treatment of Aβ-related dementias,
including AD and cerebral amyloid angiopathy.
Physiologically, two major enzymes are predominantly
implicated in the partial degradation of Aβs: NEP and
IDE [6, 16]. NEP is a membrane-anchored zinc-
dependent endopeptidase, being able to cleave both Aβ
monomers and oligomers. The role of NEP in the patho-
genesis of AD is indicated by its decreased expression in
the AD brain, particularly in vulnerable regions such as
the hippocampus and the midtemporal gyrus, a
phenomenon associated with increased Aβ-deposition
[54]. IDE, a thiol- and zinc-dependent metallopeptidase,
appears to participate in the catabolism of insulin and
Aβ as well, and its decreased expression was reported in
the hippocampus of AD patients [55]. Although IDE me-
diates these processes in vivo, it still remains a question
how this cytoplasmic protein can degrade extracellular
Aβ aggregates in the brain. Further relevant membrane
proteases involved in Aβ degradation include plasmin,
cathepsin B, endothelin-converting enzyme, and certain
members of matrix metalloproteinase family, which are
highly tissue- and brain region-specific [2]. Potential
therapeutic approaches to reduce the accumulation of
harmful neurotoxic proteins include the facilitation of
anti-aggregation processes or the enhancement of their
clearance. As an example, β-sheet breakers bind to the
central hydrophobic core of Aβ1–42 and attenuate the
formation of the β-sheet structures. These molecules
could destabilize the senile plaques; however, they do
not provide adequate solution to the degradation and
catabolism of overexpressed toxic aggregates. [40]
Therefore, an ideal protective strategy against aggregate-
induced neuronal damage requires more complex and
practical solutions, with dual mechanisms of action
targeting both the destabilization and degradation of
toxic aggregates.
Treatments with different exogenous Aβ isoforms are
widely used models of AD and earlier studies used various
in vitro and in vivo systems to reveal their exact effects. Sev-
eral studies were performed on human neuroblastoma cells
[7, 36], invertebrates, rodents, and primates [13, 20, 42];
however, only a single publication aimed at describing the
effects of Aβ on bdelloid rotifers, e.g. Philodina species [36].
This unique study by Poeggeler et al. [36] reported the treat-
ment of rotifers with Aβ1–42 in order to test the efficacy of
an antioxidant molecule (LPBNAH) against the supposed
neurotoxicity of the peptide aggregates. In their in vivo
studies with rotifers, the authors applied doxorubicin instead
of Aβ1–42, because this toxin gave more consistent results
in rotifers. In fact, the neurotoxic effect of Aβ1–42 in this
model could not be proven. Our aim was to investigate this
intriguing phenomenon that was only slightly touched upon
in the paper of Poeggeler.
Bdelloid rotifers, as microinvertebrates, are one of the
most commonly used animal models in toxicity-, aging-,
and longevity-related research. These organisms are
multicellular animals with well-defined anatomical char-
acteristics, possessing a ciliated head structure, bilateral
ovaries, mastax, ganglia, muscles, digestive, nervous, and
secretory systems, and photosensitive, and tactile organs.
[5, 15]. Due to their peculiar anatomy and physiology,
these animals have outstanding advantages in terms of
culturing and are rather easy to work with [44]. Rotifers
are extremely resistant to environmental alterations and
successfully adapt to the different types and amounts of
nutrients present in their natural habitat. The natural
decomposition of organic materials is a process that re-
sults in the formation of precipitates and aggregates,
which represent potential nutrients for rotifers [50]. The
metabolic utilization of all these available organic mater-
ial resources is their special property [4].
In a prior publication, we reported the development of a
unique and straightforward method [34], which enables
the investigation of the effect of several different agents or
impacts on various phenotypic parameters of microinver-
tebrates. The oil-covered microdrop technology, adopted
from human in vitro fertilization, is a well-controllable
construction to assess the lifespan and other features of a
single isolated animal (one-housed rotifer).
In our present study, we examined the effect of
various neurodegeneration-related peptide and protein
aggregates under complete dietary restriction, ensuring
that the individual rotifers had no other organic source
to be used for gluconeogenesis. Observing an intriguing
increase in survival upon treatment with aggregates, as a
next step, we investigated different types of micro-
entities in neurotoxic aggregate-supplemented environ-
ment. To our knowledge, this study is the first to
address the in vivo catabolism of these molecules as
dietary sources in microscopic animals such as rotifers.
Our findings may provide a starting point to understand
the possible ways of degradation of abnormally folded
neurotoxins despite their aggregated state and conse-
quent protease resistance, a subject with high potential
relevance in the treatment of neurodegenerative
proteinopathies.
Materials and methods
Materials
The Aβ1–42, Aβ1–42 [Gln22], Aβ1–40, Aβ25–35, two
scrambled isoforms (Aβ1–42 S1: LKAFDIGVEYNKVGEG-
FAISHGVAHLDVSMFGEIGRVDVHQA and Aβ1–42 S2:
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KVKGLIDGAHIGDLVYEFMDSNSAIFREGVGAGHVHV
AQVEF) were prepared in the Department of Medical
Chemistry, University of Szeged, Szeged, Hungary. The
peptides were synthesized on an Fmoc-Ala-Wang resin
using Nα-Fmoc-protected amino acids with a CEM Liberty
microwave peptide synthesizer (Matthews, NC, USA). The
peptide Aβ11–42 (H-7668.1000) was purchased from
Bachem (Torrance, CA, USA), whereas Aβ1–28 (A0184)
and α-Syn (type E46K human; S4447) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The mature part (25–
244) of recombinant bovine prion protein (PrPC, AG210)
was obtained from Merck Millipore (Darmstadt, Germany).
EZ4U (BI-5000; Biomedica Medizinprodukte, Wien,
Austria) and Calcein-AM (17,783; Sigma-Aldrich) cell
viability assays were used to measure the toxicity of the
aggregates. For in vivo and in vitro investigations of the dif-
ferent aggregates, we applied Bis-ANS (4,4′-dianilino-1,1′-
binaphthyl-5,5′-disulfonic acid dipotassium salt; D4162)
and Congo red (CR; C6277) dyes obtained from Sigma-
Aldrich. To detect gold-tagged beta-amyloid (Au-Aβ1–42)
in P. acuticornis with scanning electron microscopy (SEM),
we used Gold(III) chloride (AuCl3 x 2H2O; 01216, Reanal,
Budapest, Hungary) and Aβ1–42 aggregates. Distilled water
(DW) was prepared in our laboratory (Millipore-type, ultra-
pure, demineralized DW).
Preparation of aggregating peptides and proteins
The synthesis and characterization of the Aβ peptides
were conducted as previously described by Bozso et
al. [3] with minor modifications: the concentrations of
the stock solutions were 1 mg/mL (DW); the aggrega-
tion time was 3 h or 3 days (25 °C, pH 3.5); the
neutralization (to pH 7.5) was performed with NaOH
(1 N) [17]; after 10-fold dilution with standard
medium, the final (working) concentrations were
100 μg/mL. The amount of diluted cations and anions
in standard medium (mg/L): Ca2+ 31.05; Mg2+ 17.6;
Na+ 0.9; K+ 0.25; Fe2+ 0.001; HCO3
− 153.097; SO4
− 3; Cl
− 0.8; F− 0.02; H2SiO3 3.3 (pH = 7.5) [41]. To prepare
the PrPSc form of PrPC, the stock solution of PrPC
was aggregated for 24 h at pH 2 [49, 57]. The pH of
the prepared prion was also adjusted to pH 7.5 before
being used to treat the rotifers.
Collection, isolation, identification and harvesting of
different animal species
To collect and isolate different microscopic species, we
used the method described by Debortoli et al. [9] with
minor modifications. The sampling sites were distributed
within two areas of about 500 m2 near Szeged (Southern
Great Plain, Hungary) and Saint-George (Transylvania,
Romania). Fifty patches of highly hydrated moss (with
minimal soil) were collected from the northern side of
trees (of the genera Acer and Platanus) and from their
close environment. Briefly, the collected samples were
hydrated with the standard medium in separate flasks.
After identifying the species by using methods described
in the literature [18, 21, 24, 33, 48] we applied species-
specific information (e.g., body size in relation to age) to
collect relatively young (approximately 3–5 days old)
and individuals of the same size. The isolation protocol
from the samples was in line with the method of Debor-
toli et al. [9]. However, instead of culturing; we collected
and isolated these animals (using micropipette) to create
monoclonal populations. After washing these groups
with standard medium, we harvested as many indivi-
duals as needed (n = 30) for the experiments. The spe-
cies collected in Hungary comprised Philodina vorax
Janson, 1893; Philodina megalotrocha Ehrenberg, 1832;
Lepadella patella Müller, 1773; Lecane arcula Harring,
1914; Lecane agilis Bryce, 1892; Lecane hamata Stokes,
1896; Lecane closterocerca Schmarda, 1859; Brachionus
diversicornis Daday, 1883; Brachionus calyciflorus calyci-
florus Pallas, 1766; Brachionus forficula Wierzejski, 1891;
Caenorhabditis elegans Maupas, 1900; Typhloplana viri-
data Abildgaard, 1789; Vorticella convallaria Linnaeus,
1758; Stylonychia mytilus Müller, 1773. The species col-
lected in Romania comprised Mniobia russeola Zelinka,
1891; Adineta steineri Bartoŝ, 1951; Habrotrocha elusa
Milne, 1916; Filinia terminalis Plate, 1886; Lindia toru-
losa Dujardin, 1841; Hypsibius dujardini Doyère, 1840;
Centropyxis aculeata Ehrenberg, 1832. Processes related
to culturing and harvesting Philodina acuticornis
Murray, 1906 were performed (in artificial environment)
as previously described by our group [34]. The animals
were photographed (Nikon D5500, Nikon Corp.,
Kanagawa, Japan) under the light microscope (at 200×
magnification; Leitz Labovert FS, Wetzlar, Germany) by
taking serial images at every 5-μm intervals, yielding a
total of 20–30 photographic layers per animal, which
were subsequently merged into one superimposed pic-
ture (by using Photoshop CC software, Adobe Systems
Inc., San Jose, CA, USA) to achieve better resolution.
In vitro and in vivo treatment and monitoring
To test the previously described neurotoxic effects of the
examined aggregates in vitro, we used a differentiated SH-
SY5Y human neuroblastoma cell line (Sigma-Aldrich),
with the related culturing and differentiating methods
based completely on our previous works [7, 26]. Five-day-
old animals (as determined by BSI) were chosen for the
experiments, an age that precedes the beginning of the re-
productive stage (i.e., egg production) by 2 days. Before
treatment (using micropipette) of individual rotifers with
aggregated molecules (0.1, 10 and 100 μg/mL), the stock
solutions (1 mg/mL) were ultrasonicated (Emmi-40 HC,
EMAG AG, Mörfelden-Walldorf, Germany) for 10 min at
45 kHz to achieve sterilization and homogenization.
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During the in vivo experiments, the viability assay, the
assessments of descriptive characteristics (such as norma-
lized mean lifespan /NML/, body size index /BSI/, bright
light disturbance /BLD/, mastax contraction frequency
/MCF/, and cellular reduction capacity /CRC/), and the
assembly of the experimental setup (with the oil-covered
microdrop) were carried out as presented in detail
previously [34].
Detections of exo- and endogenic Aβ1–42 in P.
acuticornis
Optical analysis in live rotifers (Fig. 1a-d): The juvenile
(5 days old) animals were identified on the basis of their
body size as read from a calibration curve previously de-
scribed [34]. For the treatment (in 96-well plate; 3695,
Costar, Corning Inc., USA) of preselected and 1-day
starved rotifers, we used unlabelled Aβ1–42 (3 h and
3 days aggregated) as ‘food’ source. After 12 days the
content of the wells were changed to labelled Aβ1–42,
aggregated for 3 h (in vitro marked with 10 μM Bis-ANS
fluorescent dye for 30 min) or 3 days (in vitro marked
with 50 μM CR dye for 1 h). Applying 5 h treatment
(‘feeding’), we detected the optical signals (at 200×
magnification) in the digestive system (stomach and in-
testine) of individual rotifers by an optical/fluorescence
microscope (Olympus IX71, OLYMPUS, Budapest,
Hungary). The representative images demonstrate the
localization of Aβ1–42 in the body of rotifers compared
to untreated, normally fed (600 μg/mL yeast suspension)
and unfed (starved) controls (Fig. 1a-d). Unfed indivi-
duals labelled with these two dyes (control background
without Aβ1–42 treatment) have no signal (photo not
shown).
Searching for endogenous Aβ1–42 in rotifers: The
immunological detection of the presence or absence of
natural Aβ1–42 in P. acuticornis species has a central
role in interpreting the relations of Aβ1–42 and rotifers.
After harvesting, the animals were put into − 75 °C for
30 min in standard medium. The number of rotifers
were 104 per sample. The thawed animals were ultraso-
nicated (at 45 kHz at room temperature for 10 min).
The rotifer homogenate was centrifuged (300 x g for
5 min at 24 °C) to eliminate the exoskeletons of the dead
animals. The protein concentration of the supernatant
was determined by the Qubit Protein Assay Kit
(Q33212; Thermo Fisher Scientific, Wilmington, DE,
USA) following the manufacturer’s protocol. The con-
centration of the stock suspension was 340.54 μg/mL,
which was diluted to the final protein concentrations
(μg/mL) of 20, 15, 10, 5 and 1 in standard medium.
Commercially available Aβ1–42-specific sandwich
ELISA kits (Innotest Aβ1–42, 81,576, Fujirebio, Gent,
Belgium) were used according to the manufacturer’s
protocol for the quantitative detection of Aβ1–42 in the
diluted rotifer homogenate.
The Au-Aβ1–42 complex detection with SEM (Fig. 1f,
g): The stock solutions of Aβ1–42 (1 mg/mL) and AuCl3
(2.8 mg/mL) were prepared with DW. The 3-day-
aggregated Aβ1–42 solution was mixed for 2 h with the
AuCl3 solution in a 1:4 M ratio, according to the
number of Au-binding sites of monomeric Aβ1–42 (one
methionine and three histidine residues). To remove ex-
cess Au ions, two rounds of centrifugation (25,000 x g
for 10 min at 24 °C) with supernatant replacement were
used. NaOH (1 N) was applied to adjust the pH to 7.5.
Peptide content of the final pellet was determined by the
Qubit™ Protein Assay Kit (Thermo Fisher Scientific).
The middle-aged (15 days old) harvested rotifers were
starved (i.e., complete food deprivation) for 2 days. After
washing the rotifers in 6-well plates (containing 104
adherent animals per well), each well was treated with
Au-Aβ1–42 complex in a dose of 100 μg/mL for 1 day.
The wells were decanted and washed twice with stan-
dard medium and after an incubation period of 6 h (the
time to empty the digestive tract of the animals), the
wells were washed again and the populations were fixed
and dehydrated with 96% EtOH at − 75 °C for 5 min,
followed by a partial rehydration with 30% EtOH at
room temperature for 30 min. After fixation with 1%
paraformaldehyde (for 30 min), the wells were washed
twice with DW. The collected animals were transferred
with pipette to the centre of a round glass coverslip
(diameter: 12 mm, thickness: 0.15 mm; 89,167–106,
VWR International, Houston, TX, USA), and were
allowed to dry. The samples were not coated with gold.
The structural integrity of the rotifer bodies was con-
trolled with digitally recorded photographs (Nikon
D5500). The selected bodies (based on their quality)
were subjected to SEM (Zeiss EVO MA 10, Carl Zeiss,
Oberkochen, Germany) [2]. The sample-carrier coverslip
was fixed onto a stub using a double-sided carbon tape.
The fine structure of the rotifers was observed and
photo-documented with the SEM (Fig. 1f, g), operating
at 10 kV with an 8-mm working distance, using a back-
scattered electron detector in variable pressure mode at
30 Pa. The white balance of SEM photographs was
normalized.
Congo red aggregation assay
The methods described by Klunk et al. [19] and
Datki et al. [8] were used for these experiments. The
preparation and aggregation of the peptides and
proteins for the CR assay was the same as described
in the in vitro and in vivo treatment protocols. A
volume of 10 μL CR stock solution (0.5 mM) was
added to each aggregate-containing tube (490 μL;
100 μg/mL) and these mixtures were incubated for
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20 min at room temperature and shaken every
5 min (at 50 rpm for 10 s), followed by centri-
fugation at 25,000 x g for 15 min. The supernatant
was carefully removed with a pipette and the
sediment (pellet) was resuspended in standard
medium (0.5 mL). The aggregate-bound CR content
of the suspensions was measured spectrophotomet-
rically at 540 nm with a BMG NOVOStar plate
reader (BMG Labtech, Ortenberg, Germany), using a
96-well plate (Costar).
Fig. 1 Localization and demonstration of the beneficial effects of aggregated Aβ1–42 on P. acuticornis. Juvenile rotifers were selected in different groups
after 1-day starvation: fed (a; 12 days normal feeding), unfed (b; 12 days starvation) and Aβ1–42 treated (for 12 days). The Aβ1–42 in the digestive system
(stomach and intestine) of live rotifers were visualized by fluorescent Bis-ANS (c; green colour in the representative photograph; 3 h = aggregated for 3 h) and
absorbent Congo red (d; red colour in the representative photograph; 3d = aggregated for 3 days). Untreated individuals labelled with these two dyes
showed no signal (not shown). e The normalized mean lifespan (NML) of the Aβ1–42-treated animals was significantly longer than that of their normally fed
and unfed untreated controls, with a significant difference between the 3 h- and 3d–aggregated forms. Besides NML, four viability markers were measured,
including body size index (BSI), bright light disturbance (BLD), mastax contraction frequency (MCF), and cellular reduction capacity (CRC). The Aβ1–42-treated
rotifers performed significantly better than their unfed untreated controls and there were significant differences between the subgroups treated with two the
differently aggregated forms in BSI and CRC. The concentration of Aβ1–42 was 100 μg/mL; n= 30 (NML), 50 (BSI), 20 (BLD), and 24 (MCF) one-housed indivi-
dual rotifers per group; n= 24, well with normalized absorbance to rotifer number (CRC). The scale bars in the proportional representative photographs repre-
sent 20 μm (*, significant difference from the fed and Aβ1–42-treated groups; #, significant difference from the group treated with the 3 h aggregated form).
The possible distribution of the exogenous Au-Aβ1–42 complex was studied in vivo with SEM in the body of P. acuticornis: f rotifer without treatment
(background); g Au-Aβ1–42-treated rotifer. Homogenously signals of gold can be detected in Au-Aβ1–42-treated entities. Scale bar represents 10 μm
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Statistics
The error bars represent the standard error of the mean
(S.E.M.). For comparative statistical analysis, the one-way
ANOVA was used followed by the Bonferroni post hoc
test with SPSS 23.0 software for Windows. A p ≤ 0.05 was
regarded as statistically significant, with the different levels
of significance indicated as follows: p# ≤ 0.05, p** ≤ 0.01
and p*** ≤ 0.001. Kaplan-Meier curves were applied to
present the survival of the groups. The GraphPad Prism
7.0b software (GraphPad Software Inc., La Jolla, CA,
USA) was used for the illustration and statistical analysis
(log-rank; Mantel-Cox) of survival.
Results
To investigate the background of less ‘consistent results’
with Aβ1–42 toxicity in bdelloid rotifers reported by
Poeggeler et al. [36], we investigated the effect of diffe-
rent neurodegeneration-related protein aggregates on
one-housed P. acuticornis in an experimental setup [34]
inspired by that applied human in vitro fertilization (i.e.,
oil-covered microdrop). This assay system allows the
observation of our model organisms at an individual
level. First, we examined the effect of Aβ1–42, which we
predicted to be toxic to P. acuticornis. Surprisingly; how-
ever, treatment of the animals with Aβ1–42 resulted in a
significantly longer mean lifespan (51 ± 2.71 days) than
in the case of unfed (14 ± 2.29 days) and normally fed
(32 ± 2.72 days) controls. To localize and demonstrate
the presence of Aβ1–42 aggregates in the body of the
rotifers, we used β-sheet-specific fluorescent and absor-
bent dyes. Animals in the representative photographs
(Fig. 1a-d) are shown in proportional sizes and display
the strong differences between the groups. The Fig. 1c, d
show the presence of the exogenous Aβ1–42 in the
digestive system of the rotifers after ‘feeding’ ad libitum
(above is the stomach and below is the intestine). To
characterize the Aβ1–42-treated P. acuticornis animals,
we applied some previously published [34] experimental
monitoring assays. The results (Fig. 1e) are evidences to
the fact that this bdelloid rotifer can use the Aβ1–42 as
food in isolated environment without the presence of
any other organic material. The NML of groups treated
with either 3 h or 3 days aggregated Aβ1–42 signifi-
cantly increased compared to unfed (starved) controls.
The BSI and the BLD indicated phenotypical and
physiological changes of the treated animals. These
characteristics were increased by 40% and 60%
compared to untreated starved controls, respectively.
The MCF and the CRC suggested intensified energy
level as represented by neuromuscular and cellular-
redox activities. These two markers were increased by
46% and 42% compared to unfed entities, correspon-
dingly. The Aβ1–42-treated one-housed rotifer indivi-
duals performed much better in the measured
parameters than their unfed controls, and they do not
drastically differ from the normally fed counterparts.
These results suggest that Aβ1–42 is not toxic to P. acu-
ticornis and it could be used by them as an exclusive
dietary source to live and develop in an hermetically-
isolated environment. As the next step, we aimed at de-
tecting the possible presence of endogenous Aβ1–42 in
P. acuticornis species. We applied ELISA for the quanti-
tative analysis of Aβ1–42 in the rotifer homogenates.
Interestingly, our findings indicate that endogenous
Aβ1–42 is practically absent in P. acuticornis species, an
observation first reported in the literature. To localize
exogenous Aβ1–42 aggregates in the live (Fig. 1a) roti-
fers (beyond the digestive system) we applied Au-tagged
Aβ1–42 aggregates, detected with SEM (Fig. 1f, g). After
fixating and drying the Au-Aβ1–42-treated and un-
treated animals, we monitored the possible distribution
of the remnants of the potentially catabolized peptide.
We found that in Au-Aβ1–42-treated animals, the signal
of gold-ions could be found homogeneously everywhere
in their body in contrast to the untreated ones. The only
possible source of gold in the samples was the Au-Aβ1–
42 complex taken up during life, as no aspecific gold
coating was applied. These SEM photos are only
representative.
In our study, we used eleven different peptides and
proteins, with some of them being accepted as neuro-
toxic aggregates in neurodegenerative diseases (Fig. 2).
To test and confirm the toxic effect of these aggregated
peptides/proteins, we used a differentiated SH-SY5Y hu-
man neuroblastoma cell model, based on our previous
works [7, 8]. The CRC-specific EZ4U and cytoplasmic
enzyme activity-sensitive Calcein-AM assays were used
to test the potential effect of the various aggregates. The
time-dependent differences between the respective ag-
gregate solutions incubated for 3 h and 3 days were
measured with CR spectrophotometric assay [8, 19]. The
data demonstrated an inverse correlation between CR-
binding property and cellular toxicity of aggregates. The
Aβ1–28, the scrambled isoforms Aβ1–42 S1 and S2, and
PrPC demonstrated low affinity to CR and were not
toxic to SH-SY5Y cells, accordingly.
In our next experiment, we examined whether the P.
acuticornis is capable of catabolizing other neurotoxic
aggregates as well (Fig. 3). To investigate the dose-
dependency of the effect of Aβ1–42 on rotifers, we used
three different treatment concentrations (0.1, 10, and
100 μg/mL), comparing the results with those of groups
treated with equivalent concentrations of bovine serum
albumin (BSA). Interestingly, we observed the highest
median survival in the case of 100 μg/mL Aβ1–42 treat-
ment (Fig. 3a). We found that almost all Aβ peptide
forms tested (Aβ1–42, Aβ1–42 [Gln22], Aβ1–40, Aβ11–
42, Aβ1–28, Aβ1–42 S1; Aβ1–42 S2) were favourable
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nutrient sources, contrasting with Aβ25–35, which
proved to be toxic to the rotifers (Fig. 3 b-c). This ‘short’
type of Aβ has a relatively low molecular weight
(1060.27 g/mol) compared to the longer Aβ peptides
(e.g., Aβ1–42), resulting in higher molar concentration
(94.3 μM) in a 100-μg/mL dose. We tested this artificial
Aβ aggregate in a dose of 10 μg/mL as well, and we
found it also significantly toxic (NML 58 ± 5.8%; p ≤
0.01) when analysing the survival of the treated group
compared to that of unfed controls. In addition to
various Aβ isoforms, P. acuticornis was also able to
catabolize one of the most aggregation-prone forms
of α-Syn (type E46K) as well as the physiological
(PrPC) and pathological forms (PrPSc) of prion
protein (Fig. 3d). The Kaplan-Meier survival curves
demonstrate significant differences in all treatment
groups compared to the respective untreated control
curve (Fig. 3a).
To investigate the universal capability of one-housed
microscopic entities to catabolise Aβ1–42 (aggregated
for 3 h before treatment; Fig. 4), we examined 22 species
with different phylogenetic backgrounds. These species
included bdelloid rotifers: P. acuticornis, P. vorax, P.
megalotrocha, M. russeola, A. steineri, H. elusa; monogo-
nant rotifers: L. patella, L. arcula, L. agilis, L. hamate, L.
closterocerca, B. diversicornis, B. calyciflorus calyciflorus,
B. forficula, F. terminalis, L. torulosa; non-Rotifers: C.
elegans, H. dujardini, T. viridata, V. convallaria, C. acu-
leate, S. mytilus. In order to provide adequate basis for
comparison, we used an NML where the mean lifespan
of the unfed (starved) control group within the respect-
ive species were regarded as 100% (contrasting with the
comparisons in Fig. 1 where 100% was the mean lifespan
of the normally-fed group). From the all examined spe-
cies, bdelloids (Fig. 4a-f ) were the only ones that demon-
strated significantly longer NMLs (240–290%) compared
to their unfed (starved) controls (100%). As regards
other species, Aβ1–42 was either toxic (Fig. 4g-o of
monogonants and Fig. 4s-v of non-rotifers) or had no ef-
fect (Fig. 4p-r of both groups).
The results strongly suggest that P. acuticornis can
catabolize various form of toxic and non-toxic Aβs,
α-Syn, and prion aggregates and that the investigated
bdelloid rotifer species are also able to use the
neurotoxic Aβ1–42 aggregates as nutrients (ad libi-
tum). This agent is either toxic or has no effect on
the lifespan of other microinvertebrates examined,
suggesting that the catabolism of aggregates with
proteinopathy is an exceptional property of bdelloid
rotifers (Fig. 5).
Fig. 2 Aggregation-dependent neurotoxicity of different neurodegeneration-related peptides and proteins in cell culture. To test the previously
described [10, 11] toxic effect of neurodegeneration-related aggregates, we used a differentiated SH-SY5Y human neuroblastoma cell model. The
EZ4U and Calcein-AM cell viability assays were used to detect the NADH- and esterase-activity-dependent cell viability of the cultures (presented
in orange and green columns of the chart, respectively). The mean viability of the untreated control wells was regarded as 100% (the S.E.M. of
the mean was ±2.8%). The aggregation level of the proteins was measured with Congo red spectrophotometric assay (red line in the background
of the chart). The length of incubation and aggregation time (3 h = 3 h and 3d = 3 days) influenced the toxicity of the treatment in most of the
peptides and proteins tested. Significant differences (p≤ 0.01) were detected between the 3 h- and 3d–groups (no markers on columns) in both
viability assays. Significant differences could be detected between the 3 h- and 3d–aggregated forms in the Congo red assay for all Aβs, except
for Aβ11–42, Aβ1–28, Aβ1–42 S1, and Aβ1–42 S2. Alpha-synuclein (α-Syn, type E46K) and prepared ‘scrapie’ (PrPSc) form of prion protein also
showed significant in vitro toxicity, contrasting with the ineffective normal cellular prion (PrPC). The aggregation time of the prions was 1 day
(1d). Each molecule was used in 100 μg/mL concentration; n = 8 (for EZ4U and Calcein-AM) and 20 (for Congo red) wells per group. The error
bars present the S.E.M. For statistical analysis, one-way ANOVA was used followed by the Bonferroni post hoc test, and the level of significance
were p*** ≤ 0.001 (*- the significant rate of deviation from the non-toxic and non-aggregated forms /Aβ 1–28, 1–42 S1, 1–42 S2, PrPC/ in both
viability and Congo red assays)
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Discussion
The formation and accumulation of aggregated proteins
is a central feature of several neurodegenerative diseases.
The age-related dyshomeostasis promotes the aggrega-
tion of misfolded proteins. Neurodegeneration is asso-
ciated with the resistance of various aggregated
peptides and proteins to enzymatic degradation [39].
In transmissible spongiform encephalopathies, the
endogenous PrPC, composed of the pure protein
without any presence of nucleic acid components, is
converted to the pathogenic and infectious form
(PrPSc) [37]. The α-Syn is a presynaptic neuronal
protein, which contributes to the pathogenesis of PD
via its toxic aggregation [35]. Aβ peptides can accu-
mulate as senile plaques, which are regarded as one
of the hallmark alterations in AD [2, 43].
Although the degradation of these amino acid-
containing organic macromolecules has been in the
focus of neuropharmaceutical science for decades, there
have been no proper treatments developed or methods
identified for the elimination of these toxic aggregates
from living systems to date. Moreover, only a fraction of
these peptides and proteins can be efficiently digested by
proteolytic enzymes either in vitro or in vivo. [22]
In our study, we are the first to describe the existence
of the in vivo catabolism of neurotoxic aggregates by
bdelloid rotifers (e.g., Philodina acuticornis), as these mi-
croinvertebrates are capable of using even neurotoxic
aggregates as exclusive energy and organic material
sources, prolonging their lifespan. The one-housed and
aggregated Aβ1–42-treated [3] P. acuticornis individuals
have significantly longer lifespan and better viability
compared to their untreated controls under complete
dietary restriction in a fully isolated environment. This
capability to improve (NML) or maintain (BSI, BLD,
MCF and CRC) viability showed a correlation with the
aggregation state (i.e., CR affinity) of Aβ1–42. The
administered exogenous peptide aggregates were first lo-
calized and distributed within the digestive system of the
rotifers, providing evidence of being consumed (Fig. 1).
First in the literature, we demonstrated that this species
have no detectable endogenous Aβ1–42 production.
Since the treated P. acuticornis maintained its well-
being, function, and redox capacity, we presume that
these aggregates may serve as an obligatory energy
source for gluconeogenesis in these experimental condi-
tions. Prolonged starvation of animals causes significant
physiological changes supplying glucose from amino
Fig. 3 The effect of different neurodegeneration-related aggregates on the survival of P. acuticornis. The Kaplan-Meier curves demonstrate
the survival of rotifers (n = 24 one-housed individuals per sample type; aggregation time: 3 h = 3 h and 3d = 3 days). a Dose dependency:
the effect of 3 h–aggregated Aβ1–42 and BSA were tested in three different concentrations. This neurotoxic peptide as well as the non-
toxic protein served as nutriments to rotifers. The survival was dose-dependent (0.1, 10, and 100 μg/mL) and was significantly higher in
both type of treatments compared to the untreated control group (UC; p < 0.001; log-rank test). b Natural Aβ isoforms: we tested four
natural variants of the Aβ peptide (1–42 [Gln22], 1–40, 11–42 and 1–28) on rotifers in two different aggregated forms (3 h and 3d). All
types of natural Aβs had a positive effect on the survival of the treated rotifers compared to the UC (a). c Artificial Aβ isoforms: the roti-
fers were able to use both scrambled forms of Aβ1–42 (S1 and S2) as nutrients. As a unique exception in the series, Aβ25–35 was toxic
to the rotifers, decreasing their survival as compared to the UC (a). All three types of artificial Aβs were measured in 3 h- and 3d–aggre-
gated forms. d Non-Aβ proteins: the animals treated with alpha-synuclein (α-Syn, type E46K; in 3 h- and 3d–aggregated forms) and the
cellular (PrPC) or ‘scrapie’ (PrPSc) forms of prion protein (1d = aggregated for 1 day) also showed a significantly longer lifespan compared
to the UC (a). Each protein was used in 100 μg/mL concentration. The significance of log-rank (Mantel-Cox) test was p < 0.0001 in the
statistical analyses in panels b-d. Median survival (ms) values in days are presented in the graphs. The statistical analysis of survival was
performed by GraphPad Prism 7.0b
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acids by metabolism, including ketogenesis and gluco-
neogenesis. The main function of gluconeogenesis is to
maintain the glucose level via its endogenous de novo
production from non-carbohydrate substrates, such as
glycerol, lactate, or glycogenic amino acids [28]. In
rotifers, the resting eggs contain large amounts of non-
carbohydrate substrates as obligatory sources for vital
anabolic processes during dormancy and hatching via
glyoxylate cycle and gluconeogenesis [10]. The bdelloids
are extremely resistant to starvation, which has been
shown to extend their lifespan [31], suggesting that the
enzymatic machinery required for endogenous de novo
glucose production may play a crucial role in their me-
tabolism. On this basis, their observed survival in the
presence of an aggregated peptide suggests its partial
catabolism.
In order to assess the toxicity of the examined ag-
gregated molecules, the same treatment agents were
tested on differentiated SH-SY5Y neuroblastoma cell
cultures [7, 26]. The α-Syn and PrPSc, similar to the
known toxic Aβs, caused significant reduction of
viability, in correlation with their aggregation state
(CR affinity). Our in vitro results (Fig. 2) were in line
with our a priori expectations and the academic
literature [45, 56].
The catabolic capability of P. acuticornis was not
limited to Aβ1–42 (Fig. 3). In the absence of any other
potential dietary source, the presence of other
neurodegeneration-related aggregates, such as natural
(Fig. 3b) or artificial (Fig. 3c) Aβs; α-Syn, PrPC, or PrPSc
(Fig. 3d) likewise prolonged the survival of the treated
animals compared to the untreated (unfed) controls, ex-
cept for Aβ25–35, which resulted in reduced survival.
The median survival showed association with the aggre-
gation state. These results together led us to the conclu-
sion that this extraordinary catabolic activity is universal
as regards almost any type of peptide and protein aggre-
gates. In their natural habitat, bdelloids constantly have
to cope with extreme fluctuations in nutrient availability
[4]. Furthermore, their native food source includes
particulate organic detritus, dead bacteria, algae, and
protozoa, which offer a large variety of natural
Fig. 4 The effect of Aβ1–42 on the normalized mean lifespan of different microscopic species. To investigate the universality of the ability to
catabolise 3 h–aggregated Aβ1–42 in one-housed entities, we tested 6 Bdelloids (a-f), 10 Monogonants (g-p), and 6 non-Rotifers (q-v). The data were
normalized in percent, where the mean survival of the untreated starved group of the respective species were regarded as 100%. Only bdelloids
demonstrated significantly longer lifespan compared to their starved controls after Aβ1–42 treatment. For monogonant rotifers, Aβ1–42 was either
toxic (g-o) or ineffective (p) compared to their untreated controls. A similar effect was detected in non-rotifer species, where the aggregated peptide
likewise either had no effect (q and r) or was toxic (s-v). The number in the bottom left corner of the images represents the measured real mean
survival lifespan (in days) of the untreated starved control individuals. The concentration of Aβ1–42 was 100 μg/mL n = 30 one-housed individuals per
group. For statistical analysis, one-way ANOVA was used followed by the Bonferroni post hoc test, and the levels of significance were p**≤ 0.01 and
p***≤ 0.001 (*- significant difference from the untreated starved control). Scale bars represent 50 μm
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aggregates [50]. Therefore, the capability of these ani-
mals to metabolize almost every type of aggregated pep-
tides and proteins might be an evolutionary strategy for
adaption and survival.
Our aim was to describe the existence of the in vivo
catabolism of neurodegeneration-related aggregates by
bdelloid rotifers. The results strongly indicate that these
animals can use these toxic agents as an exclusive diet-
ary source to live and grown in an hermetically isolated
environment. The available literature does not describe
any other metazoan species with a similar capability. In
species widely applied in the animal modelling of AD,
such as Caenorhabditis elegans, Drosophila mela-
nogaster, Danio rerio, or rodents, the Aβ1–42 are toxic
[11, 20, 27, 41]. Based on our experiments (Fig. 4), the
Aβ1–42 aggregates were also toxic or ineffective to the
other microscopic entities tested (monogonant rotifers
and non-rotifers). The universal capability of bdelloid
rotifers to catabolise peptide and protein aggregates (in-
cluding such that are known to be neurotoxic) implied
that the hypothetic catabolic pathway might consist of
degrading enzyme(s), their possible cofactors, and/or
anti-aggregation compounds. The comprehensive identi-
fication of the molecular background of this unique
phenomenon requires further analyses.
Conclusion
In summary (Fig. 5), we present findings indicating the
exceptional capability of the investigated bdelloids to
catabolise neurotoxic aggregates in vivo, which is to our
knowledge unprecedented in the literature regarding any
multicellular animals. In our experimental system, only
amino acids could be used for gluconeogenesis by the
rotifers; therefore, the aggregates applied represented the
only material to be catabolised in the absence of any
other food source in this isolated environment. The
one-housed P. acuticornis individuals maintain their
normal phenotypic characteristics and demonstrate
significant activity during their life, which require
constant energy production. The prolonged lifetime in
the presence of (almost all types of ) Aβs, α-Syn, PrPC
or PrPSc suggests the universal catabolic capability of
our model species as regards a wide range of peptide
or protein aggregates.
The understanding of the unique catabolic capability
of bdelloid rotifers, including P. acuticornis, on neuro-
toxic aggregates in an isolated environment without any
other energy source available may provide the basis of a
novel therapeutic approach (identification of key mole-
cules and metabolic pathways) in neurodegenerative
proteinopathies.
Fig. 5 The general capability of bdelloid rotifers to catabolise neurotoxic aggregates. Neurodegeneration-related peptide and protein aggregates
can be utilized as nutrients when given as the only potential energy source for starved bdelloid rotifer species. These agents proved to be either
toxic or ineffective for monogonant and non-rotifer species. A currently unidentified mechanism in bdelloid rotifers is hypothesized to enable the
utilization of amino acids derived from the degraded aggregates for gluconeogenesis. Compared to the unfed (starved) controls, the bdelloid
rotifers treated with aggregates (‘fed’) demonstrate increased survival and viability
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